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Abstract In the present study, we examined the amphibian
Xenopus laevis as a model for stable transgenesis and in
particular targeted transgene protein expression to the melano-
trope cells in the intermediate pituitary. For this purpose, we
have fused a Xenopus proopiomelanocortin (POMC) gene
promoter fragment to the gene encoding the reporter green
fluorescent protein (GFP). The transgene was integrated into
the Xenopus genome as short concatemers at one to six different
integration sites and at a total of one to V20 copies. During
early development the POMC gene promoter fragment gave rise
to GFP expression in the total prosencephalon, whereas during
further development expression became more restricted. In free-
swimming stage 40 embryos, GFP was found to be primarily
expressed in the melanotrope cells of the intermediate pituitary.
Immunohistochemical analysis of cryosections of brains/pitui-
taries from juvenile transgenic frogs revealed the nearly
exclusive expression of GFP in the intermediate pituitary.
Metabolic labelling of intermediate and anterior pituitaries
showed newly synthesized GFP protein to be indeed primarily
expressed in the intermediate pituitary cells. Hence, stable
Xenopus transgenesis with the POMC gene promoter is a
powerful tool to study the physiological role of proteins in a
well-defined neuroendocrine system and close to the in vivo
situation. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Recently, a number of complete genome sequences have
become available. Many of these sequences encode proteins
with an unknown function, and analysis of the roles of these
proteins will be the next scienti¢c challenge. One approach for
functional analysis concerns transfection of tumor cells in
culture. However, this approach has several drawbacks, in
particular when using cultured neuroendocrine tumor cells
since such cells have lost many of their neuroendocrine char-
acteristics [1]. A direct way to study protein function is by
generating transgenic animals to speci¢cally manipulate the
expression of the protein of interest. A unique feature of
transgenesis is namely the ability to target transgene expres-
sion in a restricted spatial and/or temporal manner by the use
of speci¢c promoter sequences. The most frequently used
transgenic experimental animal is the mouse but this approach
is time consuming and rather expensive, indicating the need
for a system to rapidly screen for the functions of many un-
known proteins. Recently, the stable introduction of a trans-
gene in the South-African claw toed frog Xenopus laevis has
been achieved [2,3]. This system can be used for the introduc-
tion of many transgene constructs in a relatively short time
and in a cost-e¡ective way.
Our interest lies in the molecular analysis of the functioning
of neuroendocrine cells. To study these cells, we use the pro-
cess of background adaptation of the amphibian X. laevis as a
model system. The dispersion of black pigment in the mela-
nophores of the skin of Xenopus is caused by the K-melano-
phore stimulating hormone (KMSH), which is secreted by the
melanotrope cells of the intermediate pituitary [4]. The pre-
cursor protein giving rise to KMSH is the prohormone pro-
opiomelanocortin (POMC) that is produced in high amounts
in active Xenopus melanotrope cells, and POMC mRNA rep-
resents about 80% of the total mRNA content in these acti-
vated cells [5]. The ¢rst melanophores develop in stage 33/34
Xenopus tadpoles [6] and the ¢rst immunoreactivity for
KMSH can be found in stage 35/36 embryos, just before the
beginning of the di¡erentiation of the adenohypophysis into
the intermediate pituitary and anterior pituitary [7]. In situ
hybridization analysis has shown that POMC mRNA can
be detected in the pituitary primordium of stage 28 hatching
embryos and in the forebrain of stage 29/30 embryos [8]. With
the more sensitive reverse transcriptase (RT)-polymerase
chain reaction (PCR) technique, POMC mRNA was detected
already in the neural plate stage (stage 13) embryos [9]. In
view of our research goal, we have used the new technique
of stable Xenopus transgenesis and the reporter green £uores-
cent protein (GFP) under the control of an approximately
500-bp X. laevis POMC gene promoter fragment to target
GFP to the melanotrope cells. This study reports for the ¢rst
time the use of Xenopus transgenesis in the ¢eld of neurobi-
ology and endocrinology, and demonstrates that this ap-
proach will be a helpful tool to establish the roles of proteins
in neuroendocrine cells.
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2. Material and methods
2.1. Generation of DNA constructs
A 529-bp DNA fragment containing nucleotides 3487 to +41 of the
Xenopus POMC gene A promoter (with +1 being the transcription
initiation site) was ampli¢ed by PCR using Xenopus genomic clone
VXPA5 [10] as a template. The primers used were: pPOMC5P : 5P-
ACGCGTCGACGGTACCCCGTGTAAATGTCCCTCTCC-3P and
pPOMC3P : 5P-TAAGAAGCTTCACTAGTCCCAAGCTGTGC-3P.
The pPOMCGFP construct was generated by replacing the CMV
promoter in the pCSGFP2 construct (kindly provided by Dr. E.
Amaya, Wellcome, Cambridge, UK) by the Xenopus POMC promoter
(SalI/HindIII fragment). The pPOMCGFP construct was checked by
cycle sequencing using the Big Dye Ready Reaction system (Perkin
Elmer), and the pPOMC5P primer. Fig. 1 presents a schematic over-
view of construct pPOMCGFP with the Xenopus POMC gene pro-
moter fragment fused to GFP cDNA.
2.2. Genomic DNA analysis
Genomic DNA was isolated either from liver of transgenic frogs or
from whole tadpoles, as described previously [11]. 5 Wg DNA, or the
total amount isolated from one tadpole, was digested with HindIII in
a volume of 100 Wl, precipitated and separated on an 0.7% agarose
gel. The gel was depurinated with 0.25 M HCl and the DNA was
transferred to Nytran Super Charge nylon transfer membrane
(Schleicher and Schuell) in 40 mM NaOH. The blot was then prehy-
bridized in Church (0.5 M Na-P, 7% sodium dodecyl sulfate (SDS),
10 mM EDTA) for 30 min, at 68‡C. 25 ng BamHI/XbaI fragment of
the pPOMCGFP construct (corresponding to the open reading frame
(ORF) of GFP) was labelled with 32P using the Random Primers
Labeling system (Gibco-BRL) and [32P]dCTP (Amersham-Pharmacia
Biotech), and used for hybridization at 68‡C in Church. The blot was
subsequently washed until 0.5USSC/0.1% SDS at 22‡C and exposed
to Kodak X-Omat X-ray ¢lm at 370‡C.
2.3. Preparation of Xenopus unfertilized eggs
Mature female Xenopus (Xenopus Express, Cape Town, South Afri-
ca), were injected in their dorsal lymphatic cavities with 375 IU hu-
man gonadotropic hormone (Pregnyl, Organon, The Netherlands) 18 h
before the removal of eggs. Eggs were squeezed from the females onto
the bottom of a petri dish, dejellied with 2% cysteine (pH 8.2) and
immediately used for transgenesis. All animal experiments were car-
ried out in accordance with the European Communities Council Di-
rective 86/609/EEC for animal welfare, and permit TRC 99/15072 to
generate and house transgenic X. laevis.
2.4. Generation of transgenic Xenopus embryos
A 1557-bp SalI/NotI fragment containing the pPOMCGFP con-
struct and the SV40 pA signal (Fig. 1) was puri¢ed using a Qiaex II
Gel Extraction Kit (Qiagen). This fragment (100 ng/2 Wl) was mixed
with sperm nuclei (2.5U105 in 2.5 Wl). The mixture was diluted to 500
Wl and V10 nl was injected per egg. As described previously [3,12], a
Percoll gradient was used to purify the sperm nuclei, digitonin was
used for permeabilization and the restriction enzyme mediated inte-
gration reaction was omitted. Normally cleaving embryos were se-
lected at the four-cell stage and cultured in 0.1UMMR/6% Ficoll-
400 with 50 Wg/ml gentamicin at 18‡C until gastrulation (stage 12)
was reached. At that time point, embryo culturing was continued in
0.1UMMR with 50 Wg/Wl gentamicin and the temperature was raised
to 22‡C. From stage 45 onwards, tadpoles were raised in tap water at
22‡C. The presence of GFP £uorescence was examined in living em-
bryos anesthetized with 0.25 mg/ml MS222 (3-aminobenzoic acid ethyl
ester; Sigma) using a Leica MZ FLIII £uorescent stereomicroscope
and photographs were taken with a Leica DC200 color camera using
the Leica DCviewer software.
Staging of Xenopus embryos was carried out according to Nieuw-
koop and Faber [13].
2.5. Cryosectioning and immunohistochemistry
Brain-pituitary preparations were dissected from juvenile transgenic
frogs and ¢xed in 4% paraformaldehyde in phosphate-bu¡ered saline
(PBS). After cryoprotection in 10% sucrose^PBS, sagittal 20 Wm cryo-
sections were mounted on poly-L-lysine coated slides and dried for 2 h
at 45‡C. To study GFP expression, sections were directly viewed
under the £uorescent microscope.
For immunohistochemistry, sections were rinsed for 30 min in 50
WM Tris-bu¡ered saline (pH 7.6), containing 150 WM NaCl and 0.1%
Triton X-100 (TBS-TX). To prevent non-speci¢c binding, blocking
was performed with 0.5% bovine serum albumin (BSA) in TBS-TX.
An anti-serum directed against the POMC-derived adrenocortico-
tropic hormone (ACTH) [14] was used as primary antibody in a
dilution of 1:2000 for 16 h at 37‡C in TBS-TX containing 0.5%
BSA. After rinsing the slides with TBS-TX, a second antibody, goat
anti-rabbit Texas Red (Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) at a dilution of 1:50, was applied and sections were
incubated for 1 h at 37‡C. Following an additional washing step, the
sections were mounted in Citi£uor (Agar Scienti¢c, Stansted, Essex,
UK) and coverslipped. Immuno£uorescence was viewed under a Leica
DM RA £uorescent microscope and photographs were taken with a
Cohu High Performance CCD Camera using the Leica Q Fluoro
software.
2.6. Metabolic cell labelling and immunoprecipitation analysis
Neurointermediate lobes (NILs) and anterior lobes (ALs) of pitui-
taries from transgenic and wildtype Xenopus were dissected and
starved in methionine- and cysteine-free XL-15 medium (67% L-15
medium; Gibco-BRL, Gaithersburg, MD, USA) for 30 min at
22‡C. The lobes were subsequently pulsed in methionine-and cys-
teine-free medium containing 5 mCi/ml 35S- Promix (Amersham/Phar-
macia Biotech) for 3 h at 22‡C. The lobes were then homogenized on
ice in lysis bu¡er (50 mM HEPES pH 7.2, 140 mM NaCl, 1% Tween
20, 0.1% Triton X-100, 0.1% deoxycholic acid, 1 mM phenylmethyl-
sulfonyl £uoride, 0.1 mg/ml soyabean trypsin inhibitor). The lysates
were incubated on ice for 15 min, cleared by centrifugation (7 min,
13 000Ug, 4‡C) and supplemented with 0.1% SDS. 10% of the lysate
was directly separated on SDS^PAGE (total lysates), while the re-
mainder was used for immunoprecipitation, employing a 1:500 dilu-
tion of an anti-GFP anti-serum (kindly provided by Dr. B. Wieringa,
Department of Cell biology, University of Nijmegen, The Nether-
lands). Immune complexes were precipitated with protein-A Sepha-
rose (Amersham-Pharmacia Biotech) and resolved by SDS^PAGE,
and radiolabelled proteins were visualized by £uorography.
3. Results
3.1. Generation of Xenopus embryos transgenic for the Xenopus
POMC gene promoter linked to GFP cDNA
For our transgenesis studies, we cloned the promoter of
Xenopus POMC gene A (nucleotides 3487 to +41, with +1
representing the transcription initiation site [10]) by perform-
ing a PCR reaction with speci¢c POMC promoter primers on
Xenopus POMC genomic clone VXPA5 [15]. This ampli¢ca-
tion resulted in a 529-bp DNA fragment (pPOMC) that con-
tains several transcriptional regulatory elements, such as a
TATA box, a serum responsive element, activator protein-1
and -2 binding sites and a negative glucocorticoid responsive
element [15]. Also, the binding site for the pituitary-speci¢c
factor PitX1 [16], the NurRE for Nur77 [17] and elements for
Neuro1D/BETA2 binding [18] but not the binding site of the
recently identi¢ed PitX1 binding Tbox factor (Tpit [19]) are
present in this Xenopus POMC gene promoter fragment. The
fragment was subsequently used to replace the CMV pro-
moter in pCSGFP2, giving the construct pPOMCGFP (Fig.
1). To generate Xenopus transgenic for the pPOMCGFP con-
struct, the recently described [2] and subsequently modi¢ed
[3,12] method for stable Xenopus transgenesis was used. To
establish that the construct had integrated into the genome,
we isolated genomic DNA from transgenic tadpoles and from
livers of transgenic frogs. HindIII-digested genomic DNA was
analyzed on Southern blots using a probe corresponding to
the ORF of GFP. The transgene was found to be integrated
into the genome of the tadpoles and frogs in multiple conca-
temeric copies, and the number of integration sites varied
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between one and six per genome. The total number of copies
integrated varied between one and V20 per genome, as de-
termined by densitometric analysis of the Southern blot. The
prominent presence of the 2044-bp hybridizing fragment,
which is the result of tail to tail concatemerization, indicates
that most of the fragments are indeed integrated as conca-
temers (Fig. 2).
3.2. GFP expression during early development of pPOMCGFP
transgenic Xenopus
Injected, healthy looking Xenopus embryos were selected at
the four-cell cleavage stage, cultured and screened for £uores-
cence during early development. The ¢rst indication of GFP
expression in the transgenic embryos was observed around
stage 25 (i.e. before hatching). A di¡use £uorescence was de-
tected in a broad area around the presumptive eye, indicating
that the promoter fragment is active in the total prosencepha-
lon and especially in the region di¡erentiating into the eye
vesicle and future diencephalon (ST25, Fig. 3). During further
development the localization of the £uorescent signal became
more restricted to the forebrain, although some £uorescent
signal was also detected in the olfactory placode (ST31, Fig.
3). At stage 37/38, most of the £uorescence was observed in
the lower part of the forebrain, whereas the signal in the
olfactory placode still remained detectable (ST37/38, Fig. 3).
At stage 40, a clear bright signal was visible near the midbrain
in the region where the pituitary di¡erentiates. In about 50%
of the transgenic tadpoles, GFP £uorescence was also ob-
served in the anterior border region of the diencephalon
(ST40, Fig. 3). The £uorescent pituitary signal could be de-
tected until stage 50; in subsequent stages, the tissue sur-
rounding the pituitary prevented the excitation of pituitary
GFP. To examine transgene GFP expression in s stage 50
tadpoles, we dissected the brain with the pituitary attached
of a stage 56 transgenic tadpole. The most intense £uorescent
signal was located at the ventral side of the brain, in the
region of the intermediate pituitary. In whole-mount prepara-
tions, no £uorescence was observed in other brain regions
(Fig. 4).
3.3. GFP expression is localized to the intermediate pituitary
cells of pPOMCGFP transgenic Xenopus embryos
In order to investigate the exact site of GFP expression, we
dissected the brain, with the pituitary attached, of a juvenile
pPOMCGFP transgenic frog and prepared sagittal cryosec-
tions. We observed a bright £uorescent signal in the inter-
mediate lobe of the pituitary, the tissue consisting of
POMC-producing melanotrope cells. No clear GFP signal
was detected in sections containing the anterior pituitary, in
which the POMC-producing corticotrope cells are located
(Fig. 5b). To study whether the GFP protein produced by
the transgene colocalizes with endogenously expressed
POMC and its cleavage products, the sections were incubated
Fig. 1. Schematic representation of the structural organization of
the Xenopus POMC gene and the pPOMCGFP construct used for
Xenopus transgenesis. The protein-coding parts of exons I, II and
III of the Xenopus POMC gene are indicated with black boxes. The
pPOMCGFP transgene construct contains the 529-bp Xenopus
POMC gene promoter fragment including part of exon I (I*) and a
cDNA encoding the marker GFP. Indicated are restriction sites
used for isolation of the fragment for transgenesis experiments
(SalI, NotI) and for analysis of genomic DNA (HindIII).
Fig. 2. Integration of the pPOMCGFP transgene into the genome
of X. laevis. Genomic DNA was isolated from tadpoles and frogs
displaying £uorescence in the pituitary or from animals with no
£uorescence (controls). 5 Wg stage 45 embryonic genomic DNA or
genomic liver DNA was digested with HindIII and analyzed by
Southern blot using the ORF of GFP as a probe. Note the promi-
nent presence of the 2044-bp fragment that results from tail to tail
ligation, indicating that most of the fragments are integrated as tail
to tail concatemers. PC, 10 ng SalI/NotI plasmid control digested in
the presence of 5 Wg genomic DNA isolated from a control animal.
NC, negative control genomic DNA isolated from a control animal.
+, £uorescence observed in pituitary; 3, no £uorescence observed
in pituitary.
Fig. 3. GFP expression driven by the 529-bp POMC promoter frag-
ment during early Xenopus development. Expression of GFP was
detected from stage 25 onwards. At this stage (ST25) GFP is ex-
pressed in the total prosencephalon and especially in the region dif-
ferentiating into the eye vesicle and the diencephalon. At stages 31
and 37/38 (ST31 and ST37/38), expression of GFP becomes re-
stricted to the forebrain and the olfactory placode (OP). Stage 40
tadpoles (ST40) show high GFP expression in the region where the
pituitary is located. In a number of animals, GFP expression is also
found in the anterior part of the diencephalon. Note that the GFP
signal is blue, due to the correction for yolk auto£uorescence.
E, (presumptive) eye; C, cement gland; OP, olfactory placode.
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with an anti-ACTH antibody recognizing ACTH as well as
POMC itself ([14] and our unpublished observations). Immu-
noreactivity was found in the intermediate pituitary, colocal-
izing with the site of GFP expression (Fig. 5a,c). In addition,
the POMC-producing cells in the anterior pituitary and sev-
eral brain regions, for instance the ventral hypothalamic nu-
cleus (VH), were immunopositive for ACTH/POMC. We used
higher magni¢cations to study the sections at the cellular level
and to compare endogenous POMC expression with the trans-
gene-driven GFP expression in more detail. The melanotrope
cells in the intermediate pituitary were indeed found to ex-
press both POMC and GFP. The subcellular localization of
the two proteins was however di¡erent. POMC and POMC-
derived peptides were restricted to the Golgi and secretory
granules, while GFP was found both cytoplasmic and in the
nuclei of these cells (Fig. 6a^c). POMC immunoreactivity was
Fig. 4. Whole-mount analysis of GFP expression in a stage 56
pPOMCGFP transgenic Xenopus tadpole. Dorsal view on the tad-
poles brain where GFP £uorescence can be observed in the pituitary
region only after exposing the brain (A). Lateral (B) and ventral (C)
views on the transgenic brain show bright £uorescence in the pitui-
tary. tm, tectum mesencephali ; tel, telencephalon; OC, optic chias-
ma.
Fig. 5. GFP is primarily expressed in the intermediate pituitary of
pPOMCGFP transgenic juvenile Xenopus. Sagittal brain-pituitary
cryosections of a pPOMCGFP transgenic frog were analyzed.
A: Endogenous POMC expression. Sections were stained for
POMC using an anti-ACTH antibody and a Texas Red conjugated
second antibody. High levels of POMC expression were found in
the intermediate pituitary (pi), whereas lower levels of expression
were detected in a subregion of the anterior pituitary (pd; indicated
by an arrow). Other £uorescent signals were the result of auto£uo-
rescence. B: GFP £uorescence found in the intermediate part of the
Xenopus pituitary. C: Merge of direct GFP £uorescent signal and
endogenous POMC signal, showing colocalization of GFP and
POMC in the intermediate pituitary. Scale bar, 100 WM.
FEBS 25944 8-4-02 Cyaan Magenta Geel Zwart
E.J.R. Jansen et al./FEBS Letters 516 (2002) 201^207204
also found in the corticotrope cells, whereas no signal above
background was detected for GFP, indicating that the POMC
promoter fragment used for transgenesis is not or only at low
levels active in these cells (Fig. 6d^f). Similarly, the POMC-
producing cells in the VH of the brain showed immunoreac-
tivity with the anti-ACTH antibody but no GFP could be
detected in these cells (Fig. 6g^i). Taken together, these results
indicate that the transgene POMC promoter fragment is ac-
tive only in the melanotrope cells and not in other cells pro-
ducing POMC through the endogenous POMC gene promoter
(anterior pituitary, brain VH).
3.4. Biosynthesis of GFP in pPOMCGFP transgenic Xenopus
intermediate pituitary cells
To examine the amount of transgenic protein produced rel-
ative to endogenous protein expression, we metabolically la-
belled NILs and ALs of control and pPOMCGFP transgenic
juvenile frogs, and compared transgene-driven GFP protein
biosynthesis with endogenous POMC synthesis. Similar
amounts of newly synthesized POMC were produced in the
control and transgenic NILs, indicating that the POMC trans-
gene promoter fragment did not interfere with endogenous
POMC expression. Also, the 37 kDa POMC precursor protein
was similarly converted to 14^18 kDa POMC, showing that
the presence of the transgene product did not in£uence the
transport and cleavage of the endogenous POMC protein.
Analysis of total lysates of the pulsed tissues showed the 37-
kDa POMC precursor protein to be the major newly synthe-
sized protein produced in the transgenic and the wild type
NIL, whereas no prominent band of newly synthesized GFP
was observed in the transgenic tissue (Fig. 7, lanes 1,3). The
level of POMC biosynthesis was thus much higher than that
of GFP expression. Semi-quantitative analysis by densitomet-
ric scanning and taking into account the number of methio-
nines and cysteines in the two proteins, indicated that the
transgene POMC promoter fragment is V15-fold less active
in the melanotrope cells than the endogenous promoter.
Southern blot analysis of genomic DNA isolated from this
transgenic frog showed that there was only one copy of the
transgene present in the genome. Immunoprecipitation analy-
sis using an anti-GFP antibody revealed that newly synthe-
sized GFP was produced in the intermediate pituitary as a
32-kDa protein (Fig. 7, lane 5). Following a long exposure
of the gel, GFP was also detected in the transgenic AL lysate
Fig. 6. Analysis at the cellular level of brain-pituitary cryosections of pPOMCGFP transgenic juvenile Xenopus. Using an anti-ACTH antibody,
endogenous POMC was detected in the melanotrope cells of the intermediate pituitary (A), in the corticotrope cells of the anterior pituitary
(D) and in brain cells, e.g. in the VH (G). GFP expression was observed only in the melanotrope cells of the intermediate pituitary (B), and
not in the corticotrope cells or brain cells (E, H). Merging of the signals revealed co-expression of GFP and endogenous POMC in all melano-
trope cells (C) and not in the corticotrope cells or brain cells (F, I). pi = intermediate pituitary, pd = anterior pituitary, VH = ventral hypothala-
mic nucleus. Scale bar, 10 WM.
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(data not shown). Densitometric scanning revealed that the
amount of GFP produced in the AL is V1^2% of the amount
produced in the NIL, indicating that the transgene POMC
promoter fragment is not very active in the corticotrope cells.
4. Discussion
In the era of genomics and functional genomics, researchers
are constantly exploring ways to analyze the physiological
function of proteins. We use the melanotrope cells of the
South African clawed toad frog X. laevis as a model for func-
tional studies. These cells can be easily activated to transcribe
the POMC gene to high levels and to secrete large amounts of
the POMC-derived hormone K-MSH simply by placing the
animal on a black background [4]. Recently, the technique
of stable Xenopus transgenesis has been developed [2] and
simpli¢ed [3] which allowed, for the ¢rst time, the stable in-
sertion of a transgene into the genome of X. laevis, and spatial
and/or temporal transgene expression. In this study, we com-
bined the bene¢ts of our model system with the possibility to
target transgene protein expression to speci¢c tissues by stable
Xenopus transgenesis.
In order to target proteins to the melanotrope cells in the
pituitary, we cloned a 529-bp fragment of the POMC gene
promoter and used GFP as a marker protein. We found the
transgene to be successfully integrated into the genome of
Xenopus. In most cases more than one copy of the transgene
had integrated as concatemers, at up to six di¡erent sites. This
is in line with earlier studies on the use of other transgenes
where 1^8 integration sites containing single copies or short
concatemers of the transgene were found [2,3].
To get insight into the activity and speci¢city of the POMC
gene promoter fragment during early embryonic development,
we followed GFP expression in vivo. Since we observed the
presence of GFP, albeit at low levels, from stage 25 onwards,
we conclude that the promoter fragment is already active at
that stage. Previous in situ hybridization studies on the local-
ization of endogenous POMC expression during Xenopus de-
velopment showed the presence of POMC mRNA in the pi-
tuitary primordium in stage 28 and in the forebrain in stage
29/30 embryos [8]. The fact that we found GFP expression in
stage 25 embryos in the total prosencephalon indicates the
occurrence of inhibitory elements in the endogenous POMC
promoter that are not present in the fragment that was used
to drive transgenic GFP expression. Alternatively, the previ-
ously used technique of in situ hybridization may not have
been sensitive enough to detect any low endogenous POMC
promoter activity at an early developmental stage, whereas in
our present study GFP £uorescence was readily detectable.
Using the more sensitive technique of RT-PCR, POMC
mRNA has been detected already in neural plate stage 13
[9]. Apparently, the activity of the POMC gene promoter frag-
ment is not high enough to detect transgene-driven GFP ex-
pression in these young embryos. Of further interest is the
presence of GFP in the olfactory placode, in line with the
fact that the POMC-derived peptide K-MSH is also found
in this organ in X. laevis (Kramer and Roubos, manuscript
in preparation) as well as in Rana esculenta [20]. During fur-
ther development the expression of GFP became restricted to
the pituitary. In some cases, cells in the anterior part of the
diencephalon of stage 45 tadpoles were found to express GFP
as well. Since we and others have observed multiple integra-
tion sites and di¡erent copy numbers of transgene integration
among various transgenic Xenopus [2,3], the variations in
GFP expression patterns may be due to the sites of integra-
tion of the transgene.
In the intact animal, we thus observed that GFP expression
becomes restricted to the pituitary region and we therefore
decided to analyze brains with pituitaries of juvenile trans-
genic frogs to study the expression in more detail and to
compare GFP expression driven by the POMC promoter frag-
ment with endogenously produced POMC. Although in Xe-
nopus the major sites of POMC synthesis are the anterior and,
in particular, intermediate pituitary, also other brain areas
such as the hypothalamus, the olfactory bulb, the medial sep-
tum, the amygdala and the epiphysis, have been shown to
produce POMC or its cleavage products [21]. Analyzing brain
cryosections of the transgenic frogs, we did not detect any
GFP expression outside the pituitary, not even in the
ACTH-producing corticotrope cells of the anterior pituitary
or in other brain areas which produce endogenous POMC,
such as the VH.
Metabolic labelling of the pituitaries provided insight into
the level of expression of the newly synthesized transgene
GFP protein as well as into the site of transgene expression.
Also at the level of the newly synthesized protein, GFP was
almost exclusively present in the intermediate pituitary of the
transgenic frogs, albeit at a much lower level than newly syn-
thesized POMC. Since only after a long exposure time some
GFP was detected in the lysate of the anterior pituitary, the
melanotrope cells in the intermediate pituitary are indeed the
major site of transgenic GFP expression. The fact that minor
expression of GFP was found in the anterior pituitary after
Fig. 7. Analysis of newly synthesized proteins produced by pituitary
cells from pPOMCGFP transgenic Xenopus. Transgenic (+) and
wild type (3) NILs and ALs were pulsed in the presence of 35S me-
thionine and cysteine for 3 h. 10% of the total lysates was directly
analyzed (lanes 1^4). The remainder was immunoprecipitated with
an anti-GFP antibody (lanes 5^8). Total lysates and immunoprecipi-
tates were subjected to SDS^PAGE and radiolabelled proteins were
visualized by £uorography (exposure times for NIL and AL total ly-
sates were 4 and 16 h, respectively; exposure time for NIL and AL
GFP-IP was 16 h). The product indicated with GFP* (lane 5) likely
results from GFP cleavage since it is absent from the control lane
(lane 7), even in a longer exposure of the gel. The low amount of
co-immunoprecipitating 37-kDa POMC (lanes 5 and 7) is due to
non-speci¢c binding of this sticky protein.
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the metabolic labelling and not at the £uorescence level is
probably due to di¡erences in the sensitivities of the detection
methods used. Furthermore, the metabolic cell labelling
showed that the introduction of the transgene did not a¡ect
endogenous POMC biosynthesis and processing, since the
amounts of 37 and 14^18 kDa POMC were similar in the
transgenic and wild type intermediate pituitaries. This ¢nding
is in line with the observation that the transgenic frogs adapt
normally to a black background.
The fact that steady state and newly synthesized GFP was
almost exclusively present in the melanotrope cells and not or
at very low levels in the corticotrope cells of the pituitary or in
POMC-producing brain cells indicates that the 529-bp POMC
promoter fragment contains transcriptional elements that are
primarily activated in the melanotropes. Alternatively, the
promoter fragment may lack DNA elements that have an
inhibitory e¡ect on POMC gene transcription in the inter-
mediate pituitary. Previous studies by others using a 300- to
400-bp mouse POMC promoter fragment to express a report-
er protein in transgenic mice have also shown that such a
small promoter region is su⁄cient for transgene expression
in the pituitary, but not enough to express the transgene in
neuronal cells [22,23]. It has been shown that to target the
expression of transgenes into the central nervous system of the
mouse in a POMC-neuron speci¢c manner, distal 5P-sequences
(between 2 and 13 kb upstream of the POMC gene) are nec-
essary [24].
In conclusion, we have shown that the melanotrope cells of
the intermediate pituitary can be speci¢cally targeted for
transgene expression using stable Xenopus transgenesis and a
529-bp POMC gene promoter fragment. Hence, this unique
and well-de¢ned system represents an attractive tool for cost-
e¡ective and e⁄cient functional studies, and can now be used
for functional neurogenomics close to the in vivo situation.
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